valu usd unless otherwis note
lower revenu ep outlook reflect fx
view lower revenu forecast
reflect fx headwind also lower ep reflect
fx higher sg spend behind new product launch
report friday market open manag
guidanc impli revenu guid mid-
point vs rbce vs fce adjust ep
rbce vs fce busi segment
model knee revenu fce hip revenu
fce set revenu fce dental revenu
fce spine cmf revenu fce
revenu fce focu week earn call
guidanc expect manag guid constant
currenc revenu growth less y/i off-set lost
bone cement sale fx headwind also anticip
grow faster owe new product launch includ
rosa knee persona partial knee persona cementless knee persona
lower estim reflect fx headwind due manag
present recent sell-sid hc confer hear
med-tech compani anticip hit
greater expect currenc headwind especi thu
lower zbh revenu reflect
fx headwind heavili skew vs
model revenu fce
fce respect view consensu may
factor greater fx headwind manag guid
headwind also assum slightli higher sg spend thu
reduc ep forecast ep
lower price maintain outperform
rate lower pt reflect revis
model appli pe multipl cash adjust
ep estim yield pt invest thesi remain
unchang believ long-term turnaround stori
manag fix short-term goal cultur global suppli
issu ramp new product launch believ compani
go offens late achiev weight averag growth goal
y/i import catalyst aao
investor meet march showcas approv product
rosa knee
price prior trade day market close estimate unless otherwis note
believ share outperform
peer group follow key reason
believ world-wide recon market larg stabl
given recent commentari orthoped manag
team well surgeon check believ
world-wide recon market larg stabl fact
world-wide recon market growth remain stabl
y/i rang everi year
expect stabl world-wide recon trend continu
 job outlook overal economi
continu slowli improv price pressur remain
constant y/i rang includ mix
new product drive acceler growth
note sever import new/upcom
product launch acceler top-line growth
persona revis system product fuel
organ revenu growth organ
growth
new leadership unlock valu share
patienc need expect manag begin
long-term investor expect bryan hanson
turn around compani howev patienc need
remedi issu still process
fix new manag reinvest busi
drive top-line growth new knee shoulder
expect manag begin focus portfolio
manag increas weight averag
bloomberg capit market estim upside/downside/target
base case scenario price target assum
compani grow top line line market growth
rate deliv oper margin leverag
base case scenario appli multipl
peer pro-forma adjust dilut cash ep
estim scenario assum still trade
discount peer analysi support outperform
upsid scenario assum return
top-line growth suppli concern resolv
compani regain surgeon confid captur market
share scenario also assum compani new ceo
bring addit experienc medic devic manag
help lead compani also explor potenti
divestitur sever under-perform busi includ
dental scenario long-term adjust dilut
ep growth could slightli larg cap md
downsid scenario assum compani
grow top-line well market growth rate
owe continu recon share loss on-going pressur
dental bone heal spine busi final call
pure price world-wide recon market take anoth
step scenario long-term adjust cash
ep growth would mid-single-digit y/i
deriv price target appli multipl pro-forma adjust
dilut cash ep estim large-cap med-tech peer believ
discount multipl appropri given lower top-lin growth rel
peer uncertainti regard on-going manufacturing/suppli issu price target
support outperform rate
risk rate price target
impedi achiev price target rate includ company-specif risk
suspens delay launch new product normal industri risk includ
competit depend agent distributor currenc intellectu properti
reimburs slow compani end market clinic trial risk regulatori
inc design develop manufactur market reconstruct
orthopaed implant includ small/larg joint dental spinal implant trauma
product sport medicin product relat orthopaed surgic product
sport extrem trauma
interest expens net
stock compens net tax
net incom attribut zmh
sport extrem trauma
